Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
TRIKAFTA/KAFTRIO2.59B93.26%
Other cystic fibrosis (CF) products186.9M6.74%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States6.04B61.20%
Europe3.11B31.50%
Other719.8M7.29%